2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$14.04+$0.010 (+0.07%)
Price as of Aug 21, 2026 7:30 PM EDT- $481.6MMarket Cap
- 56.06%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$14.04+$0.010 (+0.07%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.03 | ||
Change | +$0.010 (+0.07%) | ||
Open | $14.14 | ||
High | $14.22 | ||
Low | $13.87 | ||
Previous Close | $14.02 | ||
Volume | 115,977 | ||
30-Day Average Volume | 239,307 | ||
1-Week Change | -5.01% | ||
1-Month Change | -9.25% | ||
1-Year Change | 56.06% | ||
3-Year Change | 198.51% | ||
5-Year Change | -28.09% | ||
Fundamentals | |||
Shares Outstanding | 34.3M | ||
Total Assets | $97.0M | ||
Market Cap | $481.6M | ||
Enterprise Value | $528.0M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$6.2M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -114 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 41 | ||
P/E | -78 | ||
PEG | -8 | ||
Price/Free Cash Flow | -120 | ||
Price/Operating Cash Flow | -123 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue